ALUR vs IMRN

ALUR exhibits severe financial distress with a Piotroski F-Score of 0/9, indicating extreme weakness in operational and financial health. The Altman Z-Score is unavailable, but the company's negative profitability, collapsing revenue growth, and negative ROA (-71.87%) signal high distress risk. Despite a gross margin of 60.99%, the company is losing money at an accelerating rate, with a -187.87% profit margin and -362.30% operating margin. The stock trades at a deeply discounted price of $0.53, but this reflects a market pricing in failure rather than value. Analysts have a target of $5.50, but with no consensus recommendation and a 5-year return of -99.8%, the outlook remains bleak.

The deterministic health profile is weak, headlined by a Piotroski F-Score of 3/9, indicating significant financial deterioration. While the company maintains a strong liquidity position with a Current Ratio of 8.04 and negligible debt (D/E 0.02), these are offset by severe operational losses and a profit margin of -62.14%. The stock is in a clear long-term downtrend, losing over 85% of its value over five years, and the lack of recent earnings data suggests a lack of transparency or momentum. Despite trading below book value (P/B 0.70), the fundamental decay outweighs the valuation discount.